Schober A A - OmicsDI

Show results for

Unknown (394)
Transcriptomics (17)
Proteomics (15)
Genomics (3)
Metabolomics (1)

Organisms

Schizophyllum commune H4-8 (14)
Mycobacterium tuberculosis SP7 (14)
Salmonella enterica subsp. enterica serovar Typhimurium str. T000240 (14)
Oryza sativa Japonica Group (14)
Rabbit calicivirus (14)
Crotalus durissus terrificus (14)
Eriocheir sinensis (14)
Candidatus Endoriftia persephonae (14)
Mycobacterium tuberculosis SP10 (14)
Mycobacterium tuberculosis SP13 (14)
Cotesia typhae (14)
Mycobacterium tuberculosis SP22 (14)
Cepaea nemoralis (14)
Enterobacter ludwigii (14)
Trichoderma asperellum CBS 433.97 (14)
Corynebacterium diphtheriae bv. mitis str. ISS 3319 (14)
Nakaseomyces glabratus (14)
Olea europaea (14)
Chlamydomonas reinhardtii (14)
Lama (14)
Planorbella pilsbryi (14)
Wolbachia sp. wMelPop (14)
Pyricularia oryzae P131 (14)
Enterococcus mundtii CRL35 (14)
Pongo pygmaeus (14)
Gryllodes sigillatus (14)
Mus musculus (12)
Homo sapiens (4)
Escherichia coli O157:H7 (1)
Schizosaccharomyces pombe (1)

Organisms

Homo sapiens (2)

Repository

biostudies-arrayexpress (18)
pride (14)
ENA (2)
MassIVE (1)
MetaboLights (1)

Tissue

Cell culture (5)
Larva (4)
Heart (3)
Fibroblast (2)
Embryonic stem cell (2)
Neuroepithelial stem cell (1)
Hematopoietic stem cell (1)
Urinary bladder (1)
Kidney (1)
Liver (1)

Disease

Mitochondrial metabolism disease (3)
Neurodegeneration (1)
Inherited metabolic disorder (1)

Technology Type

Mass Spectrometry (14)
Shotgun proteomics (12)
Mass spectrometry (1)
Mass spectrometry imaging (1)
SRM/MRM (1)

Instrument Platform

Illumina HiSeq 1500 (2)
Illumina Genome Analyzer II (1)
LTQ Orbitrap (1)
Liquid Chromatography MS - negative - reverse phase (1)
Liquid Chromatography MS - positive - reverse phase (1)

Publication Date

2021 (7)
2013 (6)
2014 (5)
2012 (4)
2022 (3)
2015 (2)
2020 (2)
2019 (2)
2011 (1)
2010 (1)

CHEBI ID

CHEBI:26267 (1)
CHEBI:189577 (1)
CHEBI:189581 (1)
CHEBI:189579 (1)
CHEBI:189576 (1)
CHEBI:189575 (1)
CHEBI:183365 (1)
CHEBI:180830 (1)
CHEBI:183112 (1)
CHEBI:147432 (1)
CHEBI:26873 (1)
CHEBI:147428 (1)
CHEBI:76116 (1)
CHEBI:189580 (1)
CHEBI:76173 (1)
CHEBI:18215 (1)
CHEBI:174975 (1)
CHEBI:189578 (1)
CHEBI:87247 (1)
CHEBI:31763 (1)
CHEBI:4775 (1)
CHEBI:28819 (1)
CHEBI:27994 (1)
CHEBI:92460 (1)
CHEBI:73515 (1)
CHEBI:15864 (1)
CHEBI:70082 (1)
CHEBI:131449 (1)
CHEBI:75697 (1)
CHEBI:75677 (1)

Metabolite Name

Flavan-3ol-hexoside (1)
Syringetin 3-O-(6-acetyl)-glucoside (1)
Isorhamnetin 3-O-(6-acetyl)-glucoside (1)
Laricitrin 3-O-(6"-acetyl)-glucoside (1)
Caftaric sulfo (1)
2-S-glutathionyl-caffeoylcaftaric acid (1)
Proanthocyan (1)
Proanthocyanidin type B (1)
Procyanidin A (1)
Caffeic acid sulfonate (1)
Uridine monophosphate or pseudouridine monophosphate (1)
Uridine or pseudouridine (1)
Dihydroisorhamnetin sulfonate or petunidin sulfonate derivate (1)
Proanthocyanidin 4-beta-sulfonate (1)
Quercetin or luteolin rutinosde (1)
Quercetin-xyloside (1)
Pantotheine SO3H (1)
Galloyl hexoside (1)
Ferulic acid-O-glucoside (1)
Epicatechin-4-beta-sulfonates (1)
Caffeic acid+catechin condesation product (1)
Trans-piceatannol (1)
Luteolin-7-glucoside (1)
Quercetin-4-glucoside (1)
Myricetin-3-glucoside (1)
Kaempferol-3-glucoside (1)
Kaempferol-3-glucuronide (1)
Quercetin-3-glucoside (1)
Procyanidin B2-4-beta-sulfonates (1)
Ethyl caffeic (1)

First Public Date

2025 (1)
2022 (1)

Modification

4x(15)N labeled L-arginine (1)

Study type

Transcription profiling by array (8)
Transcription profiling by RT-PCR (6)
RNA-seq of coding RNA (2)
ChIP-seq (1)
RNA-seq of non coding RNA (1)

Release Date

2021 (44)
2022 (41)
2024 (36)
2025 (34)
2017 (33)
2023 (30)
2020 (30)
2019 (27)
2014 (22)
2018 (22)
2016 (20)
2015 (14)
2012 (13)
2013 (10)
2011 (9)
2010 (7)
2026 (6)
2009 (4)
2006 (3)
2007 (2)
2000 (2)
2008 (1)
2003 (1)

Lab affiliation

Department of Medical Biochemisty and Biophysics, Karolinska Institute, Sweden (2)
Department of Medical Biochemistry and Biophysics, Karolinska Institute, Sweden (2)
Department of Medical Biochemistry and Biophysics, Division of Molecular Metabolism, Karolinska Institutet, Solnavägen 9, 171 65 Solna, Sweden Max Planck Institute Biology of Ageing - Karolinska Institutet Laboratory, Karolinska Institutet, Stockholm, Sweden (1)
MBB, Karolinska Institutet, Stockholm/Sweden (1)
Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Sweden (1)
Leibniz-Institut für Alternsforschung - Fritz-Lipmann-Institut e.V. (FLI) Beutenbergstraße 11 07745 Jena (1)
Institute of Inorganic and Analytical Chemistry, Justus Liebig University Giessen, Schubertstrasse 60, D-35392 Giessen, Germany (1)
Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm 17177, Sweden Max Planck Institute Biology of Ageing - Karolinska Institutet Laboratory, Karolinska Institutet, Stockholm 17177, Sweden (1)
Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Solna/Sweden (1)
Division of Molecular Metabolism, Karolinska Institute, Retziusväg 8, 171 77 Stockholm, Sweden (1)
Medical Biochemistry and Biophysics department, Karolinska Institutet, Stockholm, Sweden (1)
University of Greifswald, Institute of Microbiology, Department of Microbial Proteomics, Felix-Hausdorff-Str. 8, 17489 Greifswald, Germany (1)

Tags

xref:PubMed:35960818 (1)
xref:PubMed:41735532 (1)

Previous page
1 / 43
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 43
Next page

Sort by:

Relevance

Page size

Nuclear retention of fission yeast dicer is a prerequisite for RNAi-mediated heterochromatin assembly

RNAseIII ribonucleases act at the heart of RNA silencing pathways by processing precursor RNAs into mature microRNAs and siRNAs. In the fission yeast Schizosaccharomyces pombe, siRNAs are generated by the RNAseIII enzyme Dcr1 and are required for heterochromatin formation. In this study, we have ana...

ORGANISM(S): Schizosaccharomyces pombe

2010-02-16 | E-GEOD-18582 | biostudies-arrayexpress

Interviewer Effects in Live Video and Prerecorded Video Interviewing

Not available

S-EPMC8690284 | biostudies-literature

Changes in miR expression profile carotid plaques induced by acutely induced flow disturbances in apoe-/- mice on a high fat diet.

Atherosclerosis is causally related to disturbed flow through low and oscillatory shear stress. In order to study the miR expression profile in atherosclerotic plaques induced by disturbed flow, partial ligation of the carotid artery was performed. This procedure results acutely in severly reduced b...

ORGANISM(S): Mus musculus

2012-12-26 | E-GEOD-26555 | biostudies-arrayexpress

Effects of a land and aquatic exercise-based program on pain, mobility and quality of life in patients with chronic low back pain: a study protocol for a randomized controlled trial.

Not available

S-EPMC12091758 | biostudies-literature

The time it takes to reveal embarrassing information in a mobile phone survey.

Not available

S-EPMC7959408 | biostudies-literature

What About Their Performance Do Free Jazz Improvisers Agree Upon? A Case Study.

Not available

S-EPMC5483471 | biostudies-literature

MiRNA expression profile in murine

This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

ORGANISM(S): Mus musculus

2013-03-27 | E-GEOD-34648 | biostudies-arrayexpress

Expression data from squamous cell carcinoma stem cells, epidermal progenitor cells and hair follicle bulge stem cells

We used microarrays to assess the global gene expression profiles of cancer stem cells which were isolated from cutaneous squamous cell carcinomas which developed when WT, TGF beta receptor II ko, FAK KO, and TGF beta receptor II/FAK double KO were subjected to continuous DMBA treatment. Squamous ce...

ORGANISM(S): Mus musculus

2011-12-30 | E-GEOD-29328 | biostudies-arrayexpress

MiRNA expression profile in murine advanced atherosclerotic plaque compared with un-diseased arterial wall

Aberrantly expressed miRNAs contribute to developmental abnormalities and diseases such as cancer, diabetes, and cardiovascular disorders, by hybridizing to specific mRNA targets and repressing their translation into proteins. Although miRNA expression signature is characterized in the process of ne...

ORGANISM(S): Mus musculus

2013-03-27 | E-GEOD-34644 | biostudies-arrayexpress

MiRNA expression profile in murine early atherosclerotic plaque compared with un-diseased arterial tissue

ORGANISM(S): Mus musculus

2013-03-27 | E-GEOD-34645 | biostudies-arrayexpress

Previous page
1 / 43
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 43
Next page

Sort by:

Relevance

Page size

430 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

First Public Date

Modification

Study type

Release Date

Lab affiliation

Tags

OmicsDI is part of the ELIXIR infrastructure

Tweets